AcuityMD is a commercial platform built for the medical technology industry. Thousands of sales and marketing professionals use AcuityMD to identify target markets, surface top opportunities, and grow their business.

• Branding, positioning and messaging
• Presentation design
• Web design & development
• Collateral, display graphics
• Social media & email 

Make the most of each opportunity and meeting that you get at LSI. Tighten your pitch deck storytelling and visuals. Elevate your social media presence. Make sure your message is simple to understand. See if www.alluviastudio.com can help you get there quickly and easily.

AlphaSense is the AI platform redefining market intelligence and workflow orchestration, trusted by thousands of leading organizations to drive faster, more confident decisions in business and finance. The platform combines domain specific AI with a vast content universe of over 500 million premium business documents — including equity research, earnings calls, expert interviews, filings, news, and internal proprietary content. Purpose-built for speed, accuracy, and enterprise-grade security, AlphaSense helps teams extract critical insights, uncover market-moving trends, and automate complex workflows with high quality outputs. With AI solutions like Generative Search, Generative Grid, and Deep Research, AlphaSense delivers the clarity and depth professionals need to navigate complexity and obtain accurate, real-time information quickly. For more information, visit ,www.alpha-sense.com.

Aptyx is a global medtech CDMO supporting a range of clinical markets, with particular expertise in complex interventional systems and transcatheter implants. Through Aptyx Interventional Systems, we partner with innovators from early-stage concept and feasibility through clinical, commercialization, and manufacturing at scale - bringing deep experience in covered stents and frames, catheter-based delivery systems, and integrated implant-delivery solutions.

Our teams work at the system level, aligning implant and delivery system design early to improve performance, reduce risk, and accelerate time to market. This approach is supported by the broader Aptyx network with seamless access to specialized capabilities including design & development.

With a collaborative, engineering-led mindset and a proven track record supporting both startups and global strategics, Aptyx helps emerging technologies move forward with greater speed, confidence, and scalability. Learn more at Aptyx.com or follow @Aptyx on LinkedIn.

Founded in 1994, Biomerics is a leading vertically integrated medical device contract manufacturer serving the interventional device market. Trusted as a vertically integrated partner with extensive engineering expertise and solutions, Biomerics supplies 20 of the top 30 medical device OEMs globally. Biomerics provides engineering design and development services, technology transfer manufacturing services, and contract manufacturing services — including sterilization and packaging — for medical device components, subassemblies and finished medical devices. Through nine locations in the United States, two in Costa Rica and one in the Dominican Republic, Biomerics meets customers’ immediate and long-term strategic needs. With comprehensive engineering Centers of Excellence, Biomerics is a leader in performance materials, interventional medical plastics, precision extrusion, micromachining of metals and polymers, laser processing, balloons and balloon catheters, advanced catheters and steerables, guidewires, image guided intervention, micro-overmolding, micro precision stamping, metal injection molding (MIM), and complex microassembly and finished device assembly. In addition to operating under a certified ISO 13485:2016 quality system, Biomerics is FDA registered and compliant with FDA 21 CFR Part 820.

Cedars-Sinai Intellectual Property Company helps turn ideas developed by our faculty into viable innovations. Its patent portfolio generates millions of dollars each year to support Cedars-Sinai’s basic and translational biomedical research efforts.

The Cedars-Sinai Accelerator assists growing healthcare startup companies in tailoring their solutions for maximum impact, with mentorship, funding and access to the resources, personnel and network of a world-class academic medical center.

Cedars-Sinai Health Ventures invests in the expansion of companies with viable products and services likely to be adopted by Cedars-Sinai.

Drummond Scientific Company, based near Philadelphia, is a leading life science manufacturing partner with over 75 years of proven expertise. Specializing in custom, high-throughput automated solutions, Drummond sets the industry standard for precision in diagnostic device manufacturing. Drummond is dedicated to advancing life science innovation by enabling faster, more scalable, and capital-efficient production. Through its venture manufacturing model, Drummond selectively invests in early-stage partners to bring breakthrough technologies to market—offering the infrastructure, expertise, and strategic support needed to accelerate commercialization.

As the medtech industry advances with renewed vigor, traditional capabilities are being outpaced by today’s rapid-fire market. To thrive, medtech companies must proactively transform their strategies around digitalization, innovation, supply chain, market capitalization, ESG, and much more. The EY Medtech team helps clients reimagine their end-to-end business ecosystem to enable both superior care delivery and sustained growth, shaping the future with confidence.

Medmarc is the leading expert in the products liability risks facing medical technology and life sciences companies.  Medical technology and life sciences companies are vulnerable to a variety of products liability risks that are unique to their industry. We understand these risks and specialize in providing insurance and risk management solutions designed to respond to the industry's particular needs.

We partner with Life Science startups and investors worldwide to accelerate and derisk transformational innovation on the path to clinical and commercial success. Whether your goals are focused on commercialization, IPOs, or strategic exits, we are here to help tailor our expertise to meet your specific needs. As highly experienced operators, we go beyond consultancy to bring a hands-on approach to every project. Our team's wealth of functional experience is dedicated to realizing your ideas and bringing them successfully to the market.

Innovative medical technologies change lives- but only when patients can access them.

Too often, breakthrough innovations stall due to unclear reimbursement pathways and misaligned stakeholder expectations. Without early, deliberate access strategy, adoption is delayed and patient access is at risk. This is where PRIA comes in….

PRIA Healthcare partners with MedTech innovators to translate breakthrough ideas into reimbursed, scalable care. Founded more than 14 years ago in patient access operational support services, PRIA began by helping facilities and providers through prior authorization and appeals management, for novel technologies, ultimately enabling access for more than 40,000 patients.

Today, PRIA is a full-spectrum partner across reimbursement, market access, and regulatory strategy, supporting companies from early concept through commercialization. Our integrated capabilities – spanning strategic reimbursement, health economics, market access strategy, patient access, payer engagement, regulatory, and quality – are designed to connect evidence, policy, and provider economics, accelerating the adoption of healthcare innovation.

PRIA helps ensure that innovation doesn’t stall at approval- but reaches providers, scales in practice, and ultimately reaches patients.

Advancing Innovation. Unlocking Access. Delivering Impact.

Medtech organizations are undergoing unprecedented changes. Supply chain disruption, enhanced regulation, high healthcare costs, counterfeit products, cybersecurity issues and R&D challenges are just a few of the obstacles medical device manufacturers and suppliers face today. These market changes also bring opportunities to generate value and growth beyond historic industry norms.

Our team helps medtech companies streamline operations, develop innovative products, and deliver life-saving solutions to patients. 

RBrooks Group works exclusively in the Med-Tech industry to source, assess and place top talent in the United States and Europe. Roger Brooks and his team have over 80 years of combined experience assisting early stage and established medical device organizations identify and hire the best C-Suite, board member and vice president executives. We pride ourselves on our reputation and strive to be the most highly regarded executive search firm in the medical device industry

RQM+ is a global MedTech service provider focused on accelerating compliance and market success.

Through our unparalleled expertise and industry knowledge, we deliver specialized solutions and expedite the journey along the full product lifecycle for Med Device and IVD companies, from concept to commercialization to post-market.

Our portfolio of services enables the delivery of end-to-end solutions across the complete med device product lifecycle, with our:

✓ Regulatory and Quality Consulting

✓ Lab Services (Jordi Labs)

✓ Clinical Trials

✓ Reimbursement

✓ Technology Solutions

Santé invests at the forefront of Healthcare and Technology Innovation, managing over one billion in capital. Santé invests in innovative, early-stage healthcare companies across the Biotech, Medtech, and Healthtech industries.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability.

Based in Paris, London, and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical, and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage.
The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.

Founded in 1972, Sofinnova Partners is deeply established in Europe, with more than 50 years of experience backing over 500 companies and creating market leaders around the globe.

Today, Sofinnova Partners manages over €4 billion in assets.

Sonder Capital invests in teams and technologies that can transform healthcare in the medical
device, diagnostic, and healthtech sectors.

They are foundational investors, committing their energy and capital early to guide and support
companies from inception to acquisition or IPO. Core to their success is their ability and
willingness to be actively engaged with portfolio companies, partnering with entrepreneurs as
strategic advisors, providing more than just capital. 

Their insight into what it takes to bring innovative technologies to market stems from decades
of operating experience in the medtech industry. As founders, executives, and board members,
they have experienced and overcome many of the hurdles faced by entrepreneurs and
innovators.